TWI350292B - - Google Patents

Info

Publication number
TWI350292B
TWI350292B TW093108716A TW93108716A TWI350292B TW I350292 B TWI350292 B TW I350292B TW 093108716 A TW093108716 A TW 093108716A TW 93108716 A TW93108716 A TW 93108716A TW I350292 B TWI350292 B TW I350292B
Authority
TW
Taiwan
Application number
TW093108716A
Other versions
TW200505943A (en
Inventor
Toshiki Nishizawa
Original Assignee
Hayashibara Biochem Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hayashibara Biochem Lab filed Critical Hayashibara Biochem Lab
Publication of TW200505943A publication Critical patent/TW200505943A/zh
Application granted granted Critical
Publication of TWI350292B publication Critical patent/TWI350292B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1019—Tetrapeptides with the first amino acid being basic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0815—Tripeptides with the first amino acid being basic
    • C07K5/0817—Tripeptides with the first amino acid being basic the first amino acid being Arg
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0819—Tripeptides with the first amino acid being acidic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/10—Tetrapeptides
    • C07K5/1021—Tetrapeptides with the first amino acid being acidic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW093108716A 2003-03-31 2004-03-30 Polypeptide TW200505943A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003093243 2003-03-31

Publications (2)

Publication Number Publication Date
TW200505943A TW200505943A (en) 2005-02-16
TWI350292B true TWI350292B (zh) 2011-10-11

Family

ID=33127353

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093108716A TW200505943A (en) 2003-03-31 2004-03-30 Polypeptide

Country Status (9)

Country Link
US (3) US7384636B2 (zh)
EP (1) EP1614695A4 (zh)
JP (1) JP4724000B2 (zh)
KR (1) KR20060003865A (zh)
CN (1) CN100410276C (zh)
AU (1) AU2004226032B2 (zh)
CA (2) CA2734606A1 (zh)
TW (1) TW200505943A (zh)
WO (1) WO2004087767A1 (zh)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101421299A (zh) 2006-02-22 2009-04-29 株式会社林原生物化学研究所 用于诱导产生抗淀粉样β肽抗体的肽疫苗
EP2252234A4 (en) * 2008-02-08 2014-02-19 Colgate Palmolive Co DENTAL BUFFER
JP2013090574A (ja) * 2010-01-21 2013-05-16 Daiichi Sankyo Co Ltd ペプチドワクチン
RU2496867C2 (ru) 2011-04-25 2013-10-27 Закрытое акционерное общество "Научно-исследовательский институт Аджиномото-Генетика" (ЗАО "АГРИ") Способ получения l-аминокислоты семейства глутамата с использованием коринеформной бактерии
KR101979800B1 (ko) * 2012-02-16 2019-05-20 삼성전자주식회사 위젯창을 이용한 데이터 전송 시스템 및 방법
ES2701076T3 (es) 2012-11-24 2019-02-20 Hangzhou Dac Biotech Co Ltd Enlazadores hidrofílicos y sus usos para la conjugación de fármacos a las moléculas que se unen a las células
US10464955B2 (en) 2014-02-28 2019-11-05 Hangzhou Dac Biotech Co., Ltd. Charged linkers and their uses for conjugation
US20210228702A1 (en) * 2018-05-30 2021-07-29 Deutsches Krebsforschungszentrum Combined prophylactic and therapeutic vaccines
CN115403654A (zh) * 2022-05-19 2022-11-29 首都医科大学 熊果酰-Asp-Gly-Glu-Ala、其合成、活性和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5817318A (en) * 1989-05-03 1998-10-06 Connaught Laboratories Limited Synthetic peptides for an HIV-1 vaccine
ATE192326T1 (de) 1992-11-23 2000-05-15 Novamedix Distribution Ltd Vorrichtung zur förderung der durchblutung
CN1067721C (zh) * 1996-07-04 2001-06-27 中国科学院上海生物化学研究所 含前表面抗原1和2免疫决定簇的乙肝表面抗原
CN1086421C (zh) * 1997-10-14 2002-06-19 复旦大学 丙型肝炎病毒复合多价疫苗基因的合成与克隆
FR2776926B1 (fr) * 1998-04-07 2003-10-24 Inst Nat Sante Rech Med Lipopeptides inducteurs de cytotoxicite t lymphocytaire portant au moins un epitope t auxiliaire, et leurs utilisations pour la vaccination
EP1452543A3 (en) * 2000-04-26 2005-08-03 BioSynthema, Inc RGD (ARG-GLY-ASP) coupled to (neuro)peptides
AU2002363436A1 (en) * 2001-11-07 2003-05-19 Duke University Polyvalent immunogen of hiv

Also Published As

Publication number Publication date
WO2004087767A1 (ja) 2004-10-14
CA2521038A1 (en) 2004-10-14
CA2734606A1 (en) 2004-10-14
EP1614695A4 (en) 2006-10-04
US20090088390A1 (en) 2009-04-02
AU2004226032B2 (en) 2010-06-17
CN100410276C (zh) 2008-08-13
US20100280229A1 (en) 2010-11-04
KR20060003865A (ko) 2006-01-11
JPWO2004087767A1 (ja) 2006-09-07
CA2521038C (en) 2011-10-04
AU2004226032A1 (en) 2004-10-14
CN1768079A (zh) 2006-05-03
US20070020257A1 (en) 2007-01-25
US7384636B2 (en) 2008-06-10
TW200505943A (en) 2005-02-16
EP1614695A1 (en) 2006-01-11
JP4724000B2 (ja) 2011-07-13

Similar Documents

Publication Publication Date Title
BE2022C541I2 (zh)
BE2014C055I2 (zh)
BE2014C027I2 (zh)
BE2014C003I2 (zh)
BE2013C075I2 (zh)
BE2013C069I2 (zh)
BE2013C067I2 (zh)
BE2013C038I2 (zh)
BE2013C036I2 (zh)
BE2015C005I2 (zh)
JP2003245258A5 (zh)
JP2004030629A5 (zh)
JP2004073194A5 (zh)
JP2004001391A5 (zh)
JP2004226056A5 (zh)
JP2004142416A5 (zh)
JP2004212705A5 (zh)
JP2004222636A5 (zh)
JP2004110074A5 (zh)
BE2015C024I2 (zh)
JP2003306181A5 (zh)
AU2002239060A1 (zh)
AU2002256398A1 (zh)
AU2002249912A1 (zh)
AU2002253451A1 (zh)

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees